# 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia

> **NCT01587430** · PHASE4 · UNKNOWN · sponsor: **National Research Center for Hematology, Russia** · enrollment: 245 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** high dose ARA-C
- **DRUG:** standard dose ARA-C

## Key facts

- **NCT ID:** NCT01587430
- **Lead sponsor:** National Research Center for Hematology, Russia
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2014-04
- **Final completion:** 2015-01
- **Target enrollment:** 245 (ESTIMATED)
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587430, "3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01587430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*